1. Inhibitory Antibodies
  2. XmAb 5592

XmAb 5592 is a humanized, Fc-engineered anti-HM1.24 antibody with enhanced binding to FcγRIIIa and FcγRIIa receptors, augments HM1.24-specific multiple myeloma (MM) cells lysis in vitro via antibody-dependent cellular cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP).

For research use only. We do not sell to patients.

XmAb 5592 Chemical Structure

XmAb 5592 Chemical Structure

CAS No. : 1221901-33-2

Size Price Stock Quantity
1 mg USD 280 In-stock
5 mg USD 750 In-stock
10 mg USD 1200 In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

XmAb 5592 is a humanized, Fc-engineered anti-HM1.24 antibody with enhanced binding to FcγRIIIa and FcγRIIa receptors, augments HM1.24-specific multiple myeloma (MM) cells lysis in vitro via antibody-dependent cellular cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP)[1].

In Vitro

XmAb 5592 (0-1000 ng/mL) enhances antibody-dependent cellular cytotoxicity (ADCC) and ntibody dependent cellular phagocytosis (ADCP) against multiple myeloma (MM) cells. XmAb 5592 significantly augments ADCC relative to the IgG1 analog against all cell lines ranged from 5-27 ng/mL, also augments antibody dependent cellular phagocytosis (ADCP) by macrophages[1].
XmAb 5592 (0-10000 ng/mL) induces strong MM cell lysis by degranulation of NK cells even in the presence of bone marrow stromal cells (BMSCs)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

XmAb 5592 (0.3-9 mg/kg; i.p.; twice weekly for 7 doses; SCID mice with palpable RPMI8226 tumors) inhibits tumor growth in mice bearing human MM xenografts via FcγR-dependent mechanisms[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice with palpable RPMI8226 tumors[1]
Dosage: 0.3, 3 and 9 mg/kg
Administration: Intraperitoneal injection; twice weekly for 7 doses
Result: Inhibited growth of established myeloma tumors in vivo and eradicates tumors in mice.
CAS No.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[XmAb 5592]

Shipping

Shipping with dry ice.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Purity: 99.51%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
XmAb 5592
Cat. No.:
HY-P99381
Quantity:
MCE Japan Authorized Agent: